Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-109041
Filing Date
2025-08-14
Accepted
2025-08-14 17:02:14
Documents
48
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-20250630.htm   iXBRL 10-Q 1273171
2 EX-31.1 mnov-ex31_1.htm EX-31.1 15676
3 EX-31.2 mnov-ex31_2.htm EX-31.2 16134
4 EX-32.1 mnov-ex32_1.htm EX-32.1 11507
5 EX-32.2 mnov-ex32_2.htm EX-32.2 11596
  Complete submission text file 0000950170-25-109041.txt   5472313

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnov-20250630.xsd EX-101.SCH 728822
51 EXTRACTED XBRL INSTANCE DOCUMENT mnov-20250630_htm.xml XML 989997
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 251220738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)